<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="en">Creative surgery and oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Креативная хирургия и онкология</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2021-11-3-256-259</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-608</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BRIEF COMMUNICATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group></article-categories><title-group><article-title>Physico-Chemical Properties of Antiseptics in Surgery: What is not Taken into Account in Treating Long-Term Non-Healing Wounds</article-title><trans-title-group xml:lang="ru"><trans-title>Физико-химические свойства антисептических средств: что мы не учитываем в лечении длительно незаживающих ран</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Bodduluri</surname><given-names>V. P.</given-names></name><name name-style="western" xml:lang="en"><surname>Bodduluri</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Bodduluri Vishwanath Pradeep – кафедра фармацевтических наук</p><p>Хайдарабад</p></bio><bio xml:lang="en"><p>Vishwanath Pradeep – Bodduluri Department of Pharmaceutical Sciences</p><p>Hyderabad</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7603-6064</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуревич</surname><given-names>К. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Gurevich</surname><given-names>K. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гуревич Константин Георгиевич – д.м.н., профессор, кафедра здорового образа жизни</p></bio><bio xml:lang="en"><p>Konstantin G. Gurevich – Dr. Sci. (Med.), Prof., Department of Healthy Lifestyle</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9829-9463</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ураков</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Urakov</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ураков Александр Ливиевич – д.м.н., профессор, кафедра общей и клинической фармакологии</p><p>Удмуртская Республика, Ижевск</p></bio><bio xml:lang="en"><p>Alexander L. Urakov – Dr. Sci. (Med.), Prof., Department of General and Clinical Pharmacology</p><p>Izhevsk</p></bio><email xlink:type="simple">urakoval@live.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Фармацевтический институт Крави</institution><country>Индия</country></aff><aff xml:lang="en"><institution>Kravi Pharmaceutical Institute</institution><country>India</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Московский государственный медико-стоматологический университет имени А.И. Евдокимова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.I. Yevdokimov Moscow State University of Medicine and Dentistry</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Ижевская государственная медицинская академия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Izhevsk State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>01</day><month>10</month><year>2021</year></pub-date><volume>11</volume><issue>3</issue><fpage>256</fpage><lpage>259</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Bodduluri V.P., Gurevich K.G., Urakov A.L., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Bodduluri V.P., Гуревич К.Г., Ураков А.Л.</copyright-holder><copyright-holder xml:lang="en">Bodduluri V.P., Gurevich K.G., Urakov A.L.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/608">https://www.surgonco.ru/jour/article/view/608</self-uri><abstract><p>The treatment of long-term non-healing wounds in the conditions of purulent surgery departments, widely uses solutions of chemotherapeutic and antiseptic agents. The most common are the solutions of 3–6 % hydrogen peroxide and solutions of 2–10 % sodium chloride. As a rule, solutions of these drugs are used to treat non-healing, particularly, purulent wounds, bedsores and trophic ulcers. Therefore, solutions are injected into the wound area repeatedly in the form of course therapy. The findings show that the mechanism of action of these drugs and the effect of treating long-term non-healing wounds is largely determined by such physical and chemical factors of their local interaction as concentration of the main ingredients, osmotic, alkaline activity and local temperature. The findings point out the leading role of the local temperature and the dependence of the local effect on the concentration. They describe the essence of the innovative method of treatment.</p></abstract><trans-abstract xml:lang="ru"><p>При лечении длительно незаживающих ран в условиях отделений гнойной хирургии широко используются растворы химиотерапевтических и антисептических средств. До сих пор распространено применение растворов 3–6 % перекиси водорода и 2–10 % натрия хлорида. Как правило, растворы этих лекарственных средств используют для лечения незаживающих, в частности гнойных, ран, пролежней и трофических язв. Поэтому растворы вводят в область ран многократно в виде курсовой терапии. Показано, что механизм действия указанных лекарственных средств и эффект лечения длительно незаживающих ран во многом определяется такими физико-химическими факторами их локального взаимодействия, как концентрация основных ингредиентов, осмотическая, щелочная активность и локальная температура. Указывается ведущая роль локальной температуры и зависимость локального эффекта от концентрации. Описывается сущность инновационного способа лечения.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гнойная хирургия</kwd><kwd>трофические язвы</kwd><kwd>антисептические средства</kwd><kwd>санирование гнойных ран</kwd><kwd>температура</kwd><kwd>перекись водорода</kwd><kwd>натрий хлорид</kwd></kwd-group><kwd-group xml:lang="en"><kwd>purulent surgery</kwd><kwd>trophic ulcers</kwd><kwd>antiseptics</kwd><kwd>sanitization of purulent wounds</kwd><kwd>temperature</kwd><kwd>hydrogen peroxide</kwd><kwd>sodium chloride</kwd></kwd-group></article-meta></front><body><p>The number of patients with purulent and long-term nonhealing wounds and the effectiveness of their treatment with the use of existing medical standards and medicines remain the same [<xref ref-type="bibr" rid="cit1">1</xref>][<xref ref-type="bibr" rid="cit2">2</xref>]. Therefore, the issue of developing new medicines and innovative methods of treating purulent diseases remains very relevant [<xref ref-type="bibr" rid="cit3">3</xref>].</p><p>Methods to treat long-term non-healing wounds are still traditionally based on their detersion and drainage using solutions of chemotherapeutic agents, for example, sulfonamide preparations and antibiotics, and hypertonic solutions of 2–10 % sodium chloride in combination with solutions of 3–6 % hydrogen peroxide [<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>The disadvantage of these methods of treatment is that the local use of solutions of chemotherapeutic and antiseptic agents without taking into account the concentration of the main ingredients, alkaline, osmotic and temperature activity does not provide high efficiency and safety [<xref ref-type="bibr" rid="cit5">5</xref>]. The fact is that an increase in the concentration of ingredients leads to an inhibition of the division process in the regenerating tissues of the wound surface, as well as to an increase in the local irritant effect up to its transformation into a cauterizing effect [<xref ref-type="bibr" rid="cit6">6</xref>]. In particular, the application of a bandage moistened with a solution of salt and / or carbohydrate with an excessively high concentration has a denaturing effect on the granulation tissue. On the other hand, the absence of moderate alkalinity in the purulent masses within the pH of 8.4 and the local temperature within +37–42 °C does not contribute to the dissolution of thick pus and the healing of purulent wounds [<xref ref-type="bibr" rid="cit7">7</xref>][<xref ref-type="bibr" rid="cit8">8</xref>].</p><p>In this regard, we appeal to surgeons to pay attention to the great role of these physico-chemical factors in local interaction in treating long-term non-healing wounds. We are convinced that to optimize their treatment can be achieved by cleaning the wound surface by irrigation with a solution of 3 % hydrogen peroxide at a pH of 8.4 and a temperature of +37 °C.</p><p>The fact is that these physico-chemical factors of local interaction of drug solutions with thick and viscous purulent masses have been used by mankind since ancient times all over the world. This was achieved by treating long-term non-healing purulent wounds and trophic ulcers with the help of certain physio-procedures. However, until the last decades, humanity did not have scientific evidence proving the presence of these interaction factors and scientific explanations of a certain role of a certain physico-chemical factor. Therefore, official medicine has lost the ancient ways and means of treating purulent wounds. The scientific justification of these traditions appeared only at the beginning of the 20th century [<xref ref-type="bibr" rid="cit5">5</xref>].</p><p>In our opinion, an example of a scientifically justified return to the traditional treatment of purulent wounds is the invention of “A method for treating long-term nonhealing wounds” [<xref ref-type="bibr" rid="cit9">9</xref>]. The essence of this method, which includes a course of daily irrigation of the wound surface with a solution of 3 % hydrogen peroxide at a temperature of +37 °C, is to heat the wound area with infrared radiation until persistent thermal hyperemia in the wound surface, but not exceeding the temperature of +42 °C and heating during 15 minutes, to use 2–4 % sodium chloride as a hypertonic solution at a temperature of +42 °C and to subsequently apply a warming element to the dressing, maintaining the temperature of the wound area at +37 °C during the entire period until the next thermal medicinal procedure.</p><p>Pretreatment of the wound with a warm solution of 3 % hydrogen peroxide accelerates the removal of purulentnecrotic masses and the healing process, since this drug does not have a cauterizing effect and does not destroy granulation, but it accelerates metabolism in the granulating tissue. Short-term (lasting up to 15 minutes) infrared irradiation, for example, using a Sollux lamp, and warming the wound area up to +42 °C helps to accelerate the healing process, since it modulates such symptoms of inflammation as hyperthermia and hyperemia, revives and accelerates the process of true inflammation, the occurrence of granulation, but irreversible thermal damage is excluded. In turn, applying a solution of 2–4 % sodium chloride to the wound with a bandage at a temperature of +42 °C maintains an optimal hyperthermic regime, which allows even more intensively accelerating the healing process. Warming the wound area and maintaining the temperature therein within +37 °C is also intented to accelerate the healing process, since otherwise the wound area is often cooled under normal conditions.</p><p>The method can be implemented as follows. The wound surface is cleaned of purulent-necrotic masses by irrigation with a solution of 3 % hydrogen peroxide heated to +37 °C. Then the temperature of the wound surface is measured, for example, using an infrared scanner, infrared radiation from the Sollux lamp is directed to the wound surface, making sure its warmth reaches a state of hyperemia and a temperature of +42 °C. At the same time, the heating duration should not exceed 15 minutes. If hyperemia does not happen, the procedure is stopped after 15 minutes. After reaching a state of persistent hyperemia, the wound is covered with a cotton-gauze swab moistened with a solution of 2 % sodium chloride at a temperature of +42 °C, and with a warming element, such as a heating pad in order to maintain the temperature regime in the future at the level of +37 °C continuously until the next similar procedure.</p></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tretyakov A.A., Petrov S.V., Neverov A.N., Shchtinin A.F. Treatment of purulent wounds. Novosti Khirurgii. 2015; 23(6):680–7 (In Russ.) DOI: 10.18484/2305-0047.2015.6.680</mixed-citation><mixed-citation xml:lang="en">Tretyakov A.A., Petrov S.V., Neverov A.N., Shchtinin A.F. Treatment of purulent wounds. Novosti Khirurgii. 2015; 23(6):680–7 (In Russ.) DOI: 10.18484/2305-0047.2015.6.680</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Letzelter J., Hill J.B., Hacquebord J. An overview of skin antiseptics used in orthopaedic surgery procedures. J Am Acad Orthop Surg. 2019;27(16):599–606. DOI: 10.5435/JAAOS-D-18-00105</mixed-citation><mixed-citation xml:lang="en">Letzelter J., Hill J.B., Hacquebord J. An overview of skin antiseptics used in orthopaedic surgery procedures. J Am Acad Orthop Surg. 2019;27(16):599–606. DOI: 10.5435/JAAOS-D-18-00105</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wade R.G., Burr N.E., McCauley G., Bourke G., Efthimiou O. The comparative efficacy of chlorhexidine gluconate and povidone-iodine antiseptics for the prevention of infection in clean surgery: a systematic review and network meta-analysis. Ann Surg. 2020 Sep 1. DOI: 10.1097/SLA.0000000000004076. Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Wade R.G., Burr N.E., McCauley G., Bourke G., Efthimiou O. The comparative efficacy of chlorhexidine gluconate and povidone-iodine antiseptics for the prevention of infection in clean surgery: a systematic review and network meta-analysis. Ann Surg. 2020 Sep 1. DOI: 10.1097/SLA.0000000000004076. Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hirsch T., Seipp H.M., Jacobsen F., Goertz O., Steinau H.U., Steinstraesser L. Antiseptics in surgery. Eplasty. 2010;10:e39. PMID: 20526354</mixed-citation><mixed-citation xml:lang="en">Hirsch T., Seipp H.M., Jacobsen F., Goertz O., Steinau H.U., Steinstraesser L. Antiseptics in surgery. Eplasty. 2010;10:e39. PMID: 20526354</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Urakov A.L. Pus solvents as new drugs with unique physical and chemical property. Reviews on Clinical Pharmacology and Drug Therapy. 2019;17(4):89–95 (In Russ.). DOI: 10.17816/RCF17489-95</mixed-citation><mixed-citation xml:lang="en">Urakov A.L. Pus solvents as new drugs with unique physical and chemical property. Reviews on Clinical Pharmacology and Drug Therapy. 2019;17(4):89–95 (In Russ.). DOI: 10.17816/RCF17489-95</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Urakov A.L., Urakova N.A., Alies Yu.M., Nikityuk D.B., Gurevich K.G., Lovtsova L.V., et al. Physico-chemical activity of solutions as an integral part of the mechanism of local drug effect. Pharmacy. 2019;68(6):42–9 (In Russ.). DOI: 10.29296/25419218-2019-06-08</mixed-citation><mixed-citation xml:lang="en">Urakov A.L., Urakova N.A., Alies Yu.M., Nikityuk D.B., Gurevich K.G., Lovtsova L.V., et al. Physico-chemical activity of solutions as an integral part of the mechanism of local drug effect. Pharmacy. 2019;68(6):42–9 (In Russ.). DOI: 10.29296/25419218-2019-06-08</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Urakov A.L. Thermal pharmacology: history and definition. Reviews on Clinical Pharmacology and Drug Therapy. 2021;19(1):87–96 (In Russ.). DOI: 10.17816/RCF19187-96</mixed-citation><mixed-citation xml:lang="en">Urakov A.L. Thermal pharmacology: history and definition. Reviews on Clinical Pharmacology and Drug Therapy. 2021;19(1):87–96 (In Russ.). DOI: 10.17816/RCF19187-96</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Urakov A.L., Yagudin I.I., Suntsova D.O., Svetova M.D., Stolyarenko A.P. COVID-19: thick pus, mucus and sputum with streaks of blood as a cause of airway obturation in SARS and oxygen-foaming pus solvent as a medicine for their recanalization. Acta Scientific Women’s Health. 2021;3(5):75–7.</mixed-citation><mixed-citation xml:lang="en">Urakov A.L., Yagudin I.I., Suntsova D.O., Svetova M.D., Stolyarenko A.P. COVID-19: thick pus, mucus and sputum with streaks of blood as a cause of airway obturation in SARS and oxygen-foaming pus solvent as a medicine for their recanalization. Acta Scientific Women’s Health. 2021;3(5):75–7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Strelkov N.S., Urakov A.L., Korovyakov A.P., Urakova N.A., et al. A method of treating long-term non-healing wounds. RU patent 2187287. 2002 Aug 20.</mixed-citation><mixed-citation xml:lang="en">Strelkov N.S., Urakov A.L., Korovyakov A.P., Urakova N.A., et al. A method of treating long-term non-healing wounds. RU patent 2187287. 2002 Aug 20.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
